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Abstract
Background: Apoptosis occurs frequently for blastocysts cultured in vitro, where conditions are
suboptimal to those found in the natural environment. Insulin-like growth factor-1 (IGF-1) plays an
important role in preventing apoptosis in the early development of the embryo, as well as in the
progressive regulation of organ development. We hypothesize that IGF-1 and its dephosphorylated
binding protein (IGFBP-1) may be able to improve embryo culture with an associated reduced cell
death, and that the resultant increase in the total cell number of the embryo could increase the
chances of establishing an embryonic stem-cell line.
Results: In vivo fertilized zygotes were cultured in medium containing supplementary IGF-1, or
IGFBP-1/IGF-1. The stages of the resultant embryos were evaluated at noon on day five post-hCG
injection. The extent of apoptosis and necrosis was evaluated using Annexin V and propidium
iodine staining under fluorescent microscopy. The establishment of embryonic stem-cell lines was
performed using the hatching blastocysts that were cultured in the presence of IGF-1 or IGFBP-1/
IGF-1. The results show that the rate of blastocyst formation in a tissue-culture system in the
presence of IGF-1 was 88.7% and IGFBP-1/IGF-1 it was 94.6%, respectively, and that it was
significantly greater than the figure for the control group (81.9%). IGFBP-1/IGF-1 also resulted in a
higher hatching rate than was the case for the control group (68.8% vs. 48.6% respectively). IGF-1
also increased the number of Annexin V-free and propidium iodine-free blastocysts in culture
(86.8% vs. 75.9% respectively). Total cell number of blastocyst in culture was increased by 18.9%
for those examples cultured with dephosphorylated IGFBP-1/IGF-1. For subsequent stem-cell
culture, the chances of the successful establishment of a stem-cell line was increased for the IGF-1
and IGFBP-1/IGF-1 groups (IGF-1 vs. IGFBP-1/IGF-1 vs. control: 45.8% vs. 59.6% vs. 27.3%
respectively).
Conclusion:  IGF-1 or dephosphorylated IGFBP-1/IGF-1 supplement does result in an anti-
apoptotic effect for early embryo development in culture, with a subsequent increased total cell
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number resulting from cell culture. The effect is beneficial for the later establishment of a stem-cell
line.
Background
For the new generation of assisted reproductive technol-
ogy, it has been previously suggested that in order to
decrease the frequency of ovarian hyperstimulation syn-
drome and resultant multiple pregnancies, the dosage of
gonadotropin used needs to be reduced to lessen the fol-
licle stimulation [1,2]. Accordingly, the number of
oocytes retrieved and the number of embryos transferred
via IVF (in vitro fertilization) get decreased. Under such a
condition, strategies such as attempting to elicit an
increase in the number of viable embryos in vitro and a
reduction in apoptosis in order to attempt to improve the
overall quality of embryos may contribute to this
challenge.
Apoptosis occurs as natural cell death during embryonic
development.[3]. An increased rate of apoptosis has been
observed for mouse and human blastocysts cultured in
vitro in response to specific culture conditions which are
deemed to be suboptimal to those arising in the natural
environment featuring complete and stable autocrine and
paracrine systems [4–7]. In order to improve the results of
in vitro embryo culture, practitioners need concern them-
selves with three major factors: 1) the recognition of
appropriate apoptotic regulators [3,6,8], 2) the potential
for reduced cell death [3,7,8], and 3) the recognition of
appropriate maturation regulators [9,10]. Apoptotic regu-
lators include the ICE (interleukin-1b converting enzyme)
family, the family of caspases, and bcl-2 and related genes,
eg Bax [7,11,12]. In a number of previous studies, the
potential beneficial factors for embryo development have
been reported to be IGF-1, IGF-2, EGF, β-fibroblast
growth factor (β-FGF), transforming growth factor-α
(TGF-α), TGF-β, leukemia inhibitory factor (LIF), and
interleukin-6 (IL-6).[3,7,8,11–14]. The potential candi-
dates for a role as anti-apoptotic regulators in embryo cul-
ture and selected to reduce the rate of embryonic cell
death include TGF-α, IGF-1, IGF-2, insulin, and EGF
[3,8,12,14]. The objective of this study is to evaluate the
effect of IGF-1 and its cofactor, dephosphorylated IGFBP-
1, upon the preimplantation development of mouse
embryos and on the subsequent influence in the estab-
lishment of embryonic stem-cell lines.
IGF-1 is a single-chain polypeptide of 70 amino-acid resi-
dues cross-linked by three disulfide bridges [15]. This
entity IGF-1, also known as somatomedin C, is secreted
from the liver into the general circulation in a process reg-
ulated by pituitary growth hormone, it therefore mediates
the growth-promoting activity of growth hormone (GH)
[16]. Further, IGF-1 may act as a mitogenic factor for a
variety of cells and is able to elicit a control over cell pro-
liferation and differentiation [8,12,13], and IGF-1, as a
member of the IGF family, also elicits a very special and
complex autocrine and paracrine effect upon normal
ovarian function.[4,5,10]. The ovarian regulation medi-
ated by IGF-1, IGF-1R and IGFBP-1, the so-called "intrao-
varian IGF-IGFBP system" plays a significant role in the
processes of follicular development, oocyte maturation
and ovulation, and, ultimately, even the development of
the embryo [17–19]. Furthermore, the regulation of IGF-
1 through IGFBP-1 makes a comprehension of the effect
of IGF-1 more complicated than would appear to be the
case at first glance; IGFBP-1, as a transport vehicle for IGF-
1, controls the distribution of IGF-1 and the action of IGF-
1 at a cellular level [20,21]. Further, IGFBP-1 may elicit
both restricting and augmenting effects upon the action of
IGF-1, depending upon the degree of phosphorylation of
IGFBP-1 [20]. Dephosphorylated IGFBP-1, reflecting a
decreased affinity for IGF-1, acts as reservoir for IGF-1 and
stimulates the activity of IGF-1-induced DNA synthesis
[20].
The activity of the IGF system plays a role in embryo
development [7,19,22–25]. Kleffens et al. (1999)
reported that the expression of IGF system components
preceded the occurrence of apoptosis during mouse
embryo development and organ-specific development
[26]. Further, IGF-1 also prevents the likelihood of
induced apoptosis due to the inhibition of caspase-3-like
activation and Bcl-2 and Bax expression [13]. Therefore,
IGF-1 does play an important role in the prevention of
apoptosis in early embryo development and the onward
regulation of organ development. We hypothesize that
the anti-apoptotic effect of IGF-I and/or its cofactor,
IGFBP-1 upon blastomeres, and the reduced likelihood of
cell death during blastocyst formation could contribute to
an improvement in the results of in vitro embryo culture
with reduced cell death rather than the proliferation of
cells. Therefore, the possible increased total cell number
of embryos in culture with IGF-1 or IGFBP-1/IGF-1 com-
plex could benefit the subsequent embryo culture for the
establishment of embryonic stem-cell lines (Figure 1).BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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Results
The effect of IGF-1 upon in vivo fertilized mouse zygotes 
(Experiment-1)
The development of in vivo fertilized zygotes collected from six-to-
eight-week-old mice in different culture media
The results indicated below are a composite pooled from
five repeats of our tissue culture experiments involving the
in vivo fertilized mouse zygotes. The cleavage and blasto-
cyst formation rates for the embryos were evaluated daily
under an inverted microscope until day 4.3 post-fertiliza-
tion. The results show that the proportion of embryos that
arrested from the one-cell stage to the morula stage for the
experimental group (11.3 %) was lower than was the case
for the control group (18.1 %). A significant increase in
the blastocyst formation rate for the IGF-1-supplemented
group as compared to the control group (88.7% vs. 81.9%
respectively; p = 0.043) was also noted, although the
hatching rate for blastocysts did not appear to differ signif-
icantly between the two groups (Table 1).
The evaluation of the level of necrosis and apoptosis for those 
embryos cultured in different media
A total of 106 and 83 in vivo zygotes were subjected to IGF-
1-supplemented medium (IGF-1 group) and control
medium (control group), respectively. All embryos,
including those arrested at different stages of cleavage and
those that had developed into the blastocyst stage were
subjected to propidium iodide (PI) and Annexin V stain-
ing, and then examined under epifluorescence
microscopy.
The results are illustrated in Table 2, from which it can be
seen that a significant increase in the level of Annexin V-
and PI-free embryos arose for the IGF-1 group as com-
pared to the control group (86.8% vs. 75.9%; p < 0.05).
Twelve (11.3%) embryos arrested prior to blastocyst for-
mation for the IGF-1-supplemented group, and five
(4.7%) of these demonstrated PI-positive cells. All of the
Annexin V-positive and PI-negative embryos (n = 5) also
arrested prior to the blastocyst stage (Tables 1 &2). The
arrested stages for these embryos varied widely, ranging
from a two-cell stage to the morula stage. Two cleaved
embryos arrested at the eight-cell and morula stages,
respectively, and none of the blastocysts from the IGF-1
group exhibited positivity for either Annexin V or PI
stains.
Amongst the control group, there were 15 embryos which
arrested prior to the blastocyst stage, of which about one
half (7/15) were PI-positive (Figure 2B) whilst the other
half (8/15) were Annexin V-positive and PI-negative (Fig-
ure 2A). Beside these arrested embryos, five blastocysts
from the control group stained positively with Annexin V
but did not express PI fluorescence (Figure 2C).
Table 1: The effect of IGF-1 upon the developmental competence of in vivo fertilized mouse zygotes.
Culture medium Total n Zygotes arrested in one-
cell to morula stage (%)
Zygotes developed to Blastocyst (%)
Blastocyst (%) Hatched blastocyst (%)
kSOM/AA with IGF-1 106 12(11.3) 94(88.7) *
43(40.6) ** 51(48.1) **
kSOM/AA without IGF-1 83 15(18.1) 68(81.9) *
31(37.3) ** 37(44.6) **
IGF-1: 100 ng/ml. The results were pooled from 5 repeats of experiments. * P = 0.043 ** P > 0.05
The scheme of conducted experiments Figure 1
The scheme of conducted experimentsBMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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The effect of dephosphorylated IGFBP-1/IGF-1 complex 
on in vivo fertilized mouse zygotes (Experiment-2)
The results depicted below derive from the pooled results
from four repetitive experiments. The cleavage and blast-
ocyst rates of the embryos were investigated daily until
day 4.3 post-fertilization using an inverted microscope.
More embryos developed into the blastocyst stage for the
IGFBP-1/IGF-1 group than was the case for the control
group (94.6% vs. 81.9% respectively; p = 0.05). The
hatching rate for the IGFBP-1/IGF-1 group was signifi-
cantly higher than the corresponding figure for the control
group (68.8% vs. 48.6%; p = 0.026; Table 3).
The effect of dephosphorylated IGFBP-1/IGF-1 complex 
upon total blastocyst cell count (Experiment-3)
The results shown below are pooled from three repeats of
the culture experiments. The developmental stages for the
cultured embryo were determined daily until day 4.1 post-
fertilization using an inverted microscope. They were eval-
uated before hatching on the morning of day five, that is
day 4.1 post-fertilization, instead of day 4.3 post-fertiliza-
tion, because the hatching of the cultured embryos may
distort the integrity of their figures and therefore interfere
with the counting of the total cell number. In order to
enumerate the total cell number of cultured embryos, the
embryos that progressed to the blastocyst stage for both
groups were cultured in Hoechst H33342 medium (5 µg /
ml) for three to five minutes, and then mounted onto a
slide and examined under a fluorescence microscope. The
results of cell enumeration are shown in Table 4. There
appeared to be a significantly-increased total cell count for
the blastocysts deriving from the IGFBP-1/IGF-1-supple-
mented group than was the case for the control group
(87.6 ± 5.3 vs. 73.7 ± 7.1 respectively, p < 0.01; Figure 3).
IGF-1 or IGFBP-1/IGF-1-supplemented embryo culture and 
stem-cell establishment (Experiment-4)
Zygotes recovered from female mice (C57BL/6 J x C3H),
naturally mated with C3H males, were cultured in kSOM
+ amino acids (kSOM/AA) medium alone, and served as
Table 2: The effect of IGF-1 upon the in vivo fertilized embryos examined for apoptosis and necrosis with fluorescent microscopic 
examination of PI and Annexin V staining.
Study methods Propidium iodide and Annexin V --FITC studies
Culture medium Total n With PI-positive cells * With Annexin V-positive and 
PI-negative cells **
With Annexin V-positive or 
PI-positive cells ***
Without Annexin V- and PI-
positive cells ****
kSOM/AA with IGF-1 106 5(4.7%) All are arrested 
embryos
5(8.5%) All are arrested 
embryos
10(9.4%)# 96(86.8%)# All blastocysts 
and 2 arrested embryos
kSOM/AA without IGF-1 83 7(8.4%) All are arrested 
embryos
13(15.6%) Arrested embryos 
and five blastocysts
20(24.1%)# 63(75.9%)# All are blastocysts
IGF-1: 100 ng/ml. The results were pooled from 5 repeats of experiments. # P < 0.05 * With necrotic cells; at least one PI-positive cell in the 
embryo, no matter if Annexin V-stained cells are present or not. ** With apoptotic cells; at least one Annexin V-positive cell in the embryo, but no 
PI-positive cells observed. *** With apoptotic cells or necrotic cells. **** Normal without apoptotic cells or necrotic cells.
The in vivo fertilized in vitro grown embryos examined for  apoptosis and necrosis Figure 2
The in vivo fertilized in vitro grown embryos examined for 
apoptosis and necrosis. (A) A day five in vitro cultured 
embryo arrested at six-cell stage from the control group is 
observed before and after epifluorescent technique. Green 
fluorescence by Annexin V is observed over the outer cell 
membrane and means that apoptosis is underway. There is 
negative PI fluorescence at the time of harvest. (B) An 
arrested embryo at the morula stage becomes severely frag-
mented. Green fluorescence can be noted following Annexin 
V staining with simultaneous red fluroscence by PI staining. 
(C) A blastocyst cultured from the control group appears to 
be normal looking prior to epifluorescent observation. The 
same blastocyst under epifluorescent microscope shows 
apoptotic changes with Annexin V fluorescence and absence 
of PI fluorescence. (D) An apoptotic blastocyst, following 
Annexin V and PI staining, revealed green fluorescence. 
Under epifluoresvent microscope, Annexin V staining 
revealed a well fluorescent membrance with central clearing.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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the control group. The culture medium used for one
experimental group was supplemented with IGF-1 (100
ng/ml), whilst the medium for the other experimental
group was supplemented with an IGFBP-1/IGF-1 complex
(100 ng/ml). The randomly-selected hatching blastocysts
deriving from these experimental groups were placed into
feeder wells for subsequent establishment of the stem-cell
lines used herein. The embryonic stem-cell lines were
established from the inner-cell mass (ICM) of the hatched
blastocyts following 23-25 days of co-culture with an STO
feeder-cell layer, such a procedure resulting in an
increased proportion (percentage) of successfully-estab-
lished stem-cell lines (45% vs. 59.6% vs. 27.3% respec-
tively, p < 0.05; Figure 4).
Discussion
The effects of IGF-1 upon the developmental competence 
of in vivo fertilized mouse zygotes
Autocrine and paracrine secretion of growth factors, and
the timely expression of relevant specific receptors would
likely affect the success of in vitro culture of the embryos
[7,17,27]. The deprivation of necessary growth factors for
such embryos has been shown to trigger apoptosis for a
wide variety of in vitro cultured cells [4]. In recent studies
pertaining to apoptosis, it has been suggested that TGF-α
plays a critical role in the regulation of apoptosis as a "sur-
vival factor" for mouse blastocysts in vitro.[3]. Other puta-
tive survival factors for in vitro cultured embryos include
IGF-1 and PAF (platelet activating factor) [4,19,28]. It has
been previously demonstrated that culture-medium sup-
plementation with IGF-1 promoted the development of
bovine embryos to the morula stage at day five, and that
the addition of 10 µg/ml insulin to the medium increased
the cell number of bovine blastocysts cultured in vitro
[28]. Significantly-enhanced effects were shown for LIF,
IL-6, TGF-α, EGF, IGF-1, IGF-2, and TGF-βsupplement as
regards improving embryonic hatching of post-thawed
mouse morulae, in particular, the hatching rate, the level
of which ranged from 61% for the control group to 82%
for the IGF-1-supplemented group [14].
It has previously been suggested that the core anti-apop-
totic effect of IGF-1 was mediated via IGF-1R [12,29,30].
Further, the IGF-1 receptor can be activated by either IGF-
1 or insulin, however, the relative dimension of the anti-
apoptotic effect elicited by IGF-1 upon the IGF-1 receptor
would appear to be more efficient than is the case for insu-
lin [31]. Although the IGF-1 receptor and the insulin
receptor utilize a common pathway through IRS-1 (Insu-
lin receptor substrate-1) and PI3-kinase (phosphatidyli-
Table 3: The effect of dephosphorylated IGFBP-1/IGF-1 complex upon the developmental competence of in vivo fertilized mouse 
zygotes.
Culture medium Total n Zygotes arrested in one-cell to
morula stage (%)
Zygotes developed to blastocyst (%)
Blastocyst (%) Hatched blastocyst (%)
kSOM/AA with
IGFBP-1/IGF-1
93 5(15.4) 88(94.6) **
24(25.5) 64(68.8) *
kSOM/AA without
IGFBP-1/IGF-1
72 13(18.1) 59(81.9) **
22(33.3) 37(48.6) *
The results were pooled from 4 repeats of experiments. * P < 0.05, ** P = 0.050
Table 4: Dephosphorylated IGFBP-1/IGF-1 complex increases the total cell number of cultured blastocysts.
Culture Medium No of zygotes No. of blastocysts tested Total cell number of blastocysts
kSOM/AA with IGFBP-1/IGF-1 38 15 87.6 ± 5.3 *
kSOM/AA without IGFBP-1 /IGF-1 45 18 73.7 ± 7.1 *
The results were pooled from 3 repeats of experiments. * P < 0.01BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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nositol 3-kinase), the IGF-1 receptor can act through an
alternative anti-apoptotic pathway which appears to be
IRS-1 and PI3-kinase-independent and is not shared with
the insulin receptor [32]. This suggests that the mitogenic
activity of IGF-1 through the IGF-1 receptor, which corre-
lates with the tyrosine kinase domain, may be able to
elicit a more-powerful anti-apoptotic effect than expected
anti-apoptotic effect through pathway of the IRS-1. There-
fore, further studies are needed.
In our study, the benefit of supplementation of culture
medium with IGF-1 for the development of in vivo ferti-
lized embryos has clearly been demonstrated (Table 1).
The blastocyst formation rate was significantly increased
for the IGF-1-supplemented group as compared to the
control group (88.7% vs. 81.9% respectively), although
the significance did not appear to be particularly
prominent or dramatic (p = 0.043). This may be due to
the moderately high blastocyst-formation rate (81.9%)
for our control group, in which the apoptotic factors
might be less than those in other in vitro studies with low
blast-formation rate.[3,8,22,25,33]. In the studies of
Lighten et al. (1998), treating cultured human embryos
with 1.7 nM IGF-1 increased the rate of blastocyst forma-
tion by 25%, (60% versus 35% for the control; p=
0.0018).[25]. There were low blastocyst-formation rate in
their control group (35%), in which suboptimal condi-
tions with apoptotic factors may be encountered. The rel-
ative increase in the level of blastocyst formation was
greater and more dramatic in their study as compared to
ours.[25]. The anti-apoptotic effect of IGF-1 noted here
would appear to be mainly due to its role as a protector of
embryonic cells from possible injury [11,20,34]. There-
fore, as regards elevating blastocyst formation rate, the
more-prominent effect of IGF-1 would likely be deter-
mined under the more suboptimal culture conditions.
Herrler and his colleagues (1998) have demonstrated that
IGF-1 might act as a "survival factor" during preimplanta-
tion development, in which situation the apoptosis was
induced by UV irradiation (254 nm wave length; 11.8 W/
m2).[22]. Indeed, our studies have demonstrated that the
supplementation of culture medium by IGF-1 would
likely improve the blastocyst-formation rate of the in vivo
fertilized embryo cultured in vitro. This significant but not
prominent effect of IGF-1, when compared to the results
obtained in other studies with imposed apoptotic factors
[14,22], might have resulted from the absence of the
induction of a significant level of apoptosis in our experi-
mental study.
Anti-apoptotic effect
To study the survival effect of IGF-1 alone over the kSOM
cultured embryos, we observed the necrotic and apoptotic
changes as revealed by Annexin V and PI staining using an
epifluorescent microscope. As indicated in Table 2, a sig-
nificantly-lower number of apoptotic and necrotic
embryos were observed for the IGF-1-supplemented
group than was the case for the control group (9.4% vs.
24.1% respectively, p < 0.05). Further, we also noted that
there were fewer Annexin V-revealed apoptotic cells
amongst blastocysts for the IGF-1 group as compared to
the control group (n= 0 vs. n = 5 respectively). Such results
reveal a significant anti-apoptotic and, subsequently, an
anti-necrotic effect elicited by IGF-1 supplementation of
embryo culture medium.
The proportion (percentage) of apoptotic blastocysts,
revealed by only Annexin V fluorescence staining at the
termination of embryo culture in kSOM/AA medium
either with or without IGF-1 supplementation was 3.1%
(5/162), a result that appeared to be quite different from
that of Kamjoo and his colleagues in 2002 [6], from
whose studies, the apoptosis index (dead cells/total cells)
revealed with TUNEL staining for mouse embryos
cultured in kSOM was 14.4 % [1]. We were unable to
determine the dead-cell count for each blastocyst, because
the quality of the Annexin V fluorescence in the blasto-
cysts appeared to be quite scant in our study, although the
total cell number of the blastocysts examined in our study
was higher than that reported by Kamjoo and his col-
leagues in 2002 [6].
The total cell count of the H33342-stained blastocyst Figure 3
The total cell count of the H33342-stained blastocyst. An 
H33342-stained blastocyst from the control group revealed a 
total of 77 visible nuclei observed from different planes.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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In our study, the embryos were collected from F1 female
C57BL/6 mice mated with C3H males and were cultured
in kSOM/AA culture medium. Such a model appears to
demonstrate a better potential to promote blastocyst for-
mation in culture and to result in an increased blastocyst
total cell number than the models with other culture
media and strain of mouse [6,35]. The blastocyst forma-
tion rate for the control group in our study was 81.9%. By
using a MF1 x MF1 strain and C57BL6/CBA x C57BL6/
CBA mice, Kamjoo and his colleagues (2002) were able to
report a blastocyst formation rate of 62% (total cell
number = 78.0, apoptotic index = 20.3%) and 98% (total
cell number = 55.0, apoptotic index = 14.4%),
respectively for these two strains [6]. Therefore, blasto-
cysts deriving from MF1x MF1 revealed a higher apoptotic
index than did those deriving from C57BL6/CBA x
C57BL6/CBA (20.3% vs. 14.4% respectively) cultured in
kSOM medium [6]. Such difference in results may be
attributable to the different types of mouse strain used for
the different experiments [6].
Quite independently of the type of mouse strain used for
experimentation, different methods for the determination
of apoptosis, such as Annexin V, TUNEL, 4'-6-diamidino-
2-phenylindole, in situ nick translation, and Bcl-2 and Bax
protein levels, may also make for different results of detec-
tion of apoptosis.[6,8,13,22,36]. In the studies of Ber-
lerkom and Patrick in 1998 pertaining to apoptosis with
TUNEL and Annexin V staining over the oocytes, most
Annexin V fluorescence appears subsequent to the docu-
mented fragmentation of the oocytes, although such an
event appeared to occur coincidentally with PI stain-
ing.[36]. Annexin V fluorescence, however, was reported
by Berlerkom and Patrick to have only appeared to be
associated with positive PI fluorescence, thus there were
no oocytes that were stained with only Annexin V and not
featuring PI fluorescence in their studies.[36]. In these
workers' studies, no temporal or spatial relationship
between the appearance of TUNEL- and annexin V-
stained fragments in the same oocyte was reported.[36].
In our embryo studies, the process of apoptosis for
embryos did not proceed by way of the oocytes; the
plasma membrane alternations with the associated trans-
location of phosphatidyserine from the inner layer to the
outer layer, which was revealed by Annexin-V FITC stain-
ing, occurred prior to (Figure 2A) or coincidentally with
the appearance of PI-stained necrotic changes (Figure 2B).
Further, we noted that 48.1% (13/27) of arrested embryos
exhibited the Annexin V stain only (Figure 2A), although
44.4% (12/27) of arrested embryos did exhibit PI-stained
neuclei, for which the Annexin V stain was frequently
observed coincidentally (Figure 2B). This arose because
Annexin V was also able to stain the inner plasma mem-
brane of ruptured necrotic cells.
Early in our studies, we had tried some preliminary inves-
tigation with TUNEL evaluation for apoptosis at the com-
pletion of embryo culture. The frequency of observed
TUNEL fluorescence for blastocysts in vitro appeared to be
higher than that of the Annexin V fluorescence, the latter
appearing to be extremely rare for the well-developed
blastocysts. Therefore, the observed apoptotic changes
involving the DNA fragmentation of blastomeres would
appear to have resulted from the activation of an endog-
enous nuclear endonuclease, which was labeled by the
fluorescein-dUTP in the TUNEL staining technique.[37].
Such a change appeared to occur more frequently and ear-
lier for blastocysts than did the phosphatidylserine trans-
location in the plasma membrane during the apoptotic
changes of blastocysts. Therefore, in the study of Kamjoo
et al. (2002), apoptotic blastomeres were frequently seen,
this study revealing an apoptotic index of 14.4% for the
embryos collected from C57BL6/CBA x C57BL6/CBA
mice [6]. In our study, 8.5–15.6% of the cultured embryos
exhibited only Annexin V stain positivity, in which cases
the necrotic embryos were excluded by the PI stain. If this
coincidental PI-revealed necrosis in Annexin V stained
embryo was not excluded from the statistic counting of
apoptotic changes of the cultured embryos, there would
be a total of 9.4–24.1% of Annexin V-stained embryos
exhibiting ongoing apoptotic changes. Since there is no
temporal or spatial relationship between the occurrence
of TUNEL- and annexin V-staining positivity for the
degenerating oocytes, these relationships during embryo
development still need to be investigated further.[36].
The effects of IGFBP-1/IGF-1 upon the in vitro 
developmental competence of the in vivo zygotes
As shown, we had demonstrated that IGF-1 decreased the
level of apoptosis of mouse embryos in vitro. The question
thus arises, how is IGF-1 regulated and transported in the
microenvironment during the preimplantation period,
and, further, will IGFBP-1 decrease or increase the influ-
ence of IGF-1? Following on, a further question arises will
IGF-1 be transported into the ICM of an embryo? The var-
iation in apoptosis with different microenvironments and
different strains of test animals is likely to be the result of
variable embryonic expression of intracellular and
extracellular regulators. Herrler et al. (1998) used UV radi-
ation as an apoptotic factor to demonstrate that IGF-1
acted principally and significantly as a " survival
factor".[22].
IGFBP-1 is a 25 kD protein produced predominantly by
hepatocytes and decidualized ovarian endometrium
[16,20]. IGFBP-1 provides a transport vehicle for IGF-1
and IGF-II, and controls the distribution of IGF-1 and pos-
sibly directs it to a specific receptor site [16,20]. IGFBP-1
also controls IGF action at the cellular level by either
restricting or augmenting the access of IGF-1 to anBMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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appropriate receptor [16,20]. Further, IGFBP-1 appears to
reveal a very high affinity for IGF-I and IGF-II [16,20],
therefore, it usually sequesters IGF-I, acting as a reservoir
and inhibitor of IGF-1 by preventing its binding to the
IGF-I receptor site [20].
IGFBP-1 may demonstrate both stimulatory and inhibi-
tory effects upon IGF-1-induced DNA synthesis [20].
These effects relate, predominantly, to the degree of phos-
phorylation and de-phosphorylation of the IGFBP-1
molecular species, and three mechanisms, including
phosphorylation, proteolysis, and the association with
the extracellular matrix (ECM)/integrin, influence the
dissociation of IGF-1 from IGFBP-1 [16,20]. Phosphoryla-
tion of the molecule increases the affinity of IGFBP-1 for
IGF-1 and inhibits IGF-1 binding to its receptor, such that
de-phosphorylation of IGFBP-1 reduces its affinity for
IGF-1 resulting in increased IGF-1 bioavailability [16,20].
Therefore, the ratio of non-phosphorylated or a lesser
phosphorylated form to the phosphorylated form of
IGFBP-1 determines the level of IGF-1 bioactivity in vivo
[20,38]. IGFBP-1 can be effectively proteolysed into frag-
ments, which display a reduced affinity for IGF-1, such
that following phosphorylation of IGFBP-1, IGF-1 will be
The establishment of ES cell line deriving from the hatching blastocysts Figure 4
The establishment of ES cell line deriving from the hatching blastocysts. (A) The procedure for establishing ES cell line. (B) 
When the ICM-derived clump has reached the stage illustrated in figure by day 5–6th after explantation into culture, the ICM-
derived component is clearly identified from the trophoblast cell. The cell clump is ready to be disloged and transfered for 
stem cell culture. (C) Cultured embryonic stem cells following dispersion have been transferred to another culture dish for 
further growth of the ES cells. (D) Well-established ES cells line, derived from the hatching blastocysts, will aggregate to form a 
burst-like ES cell colony.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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released in a free form to bind with the IGF-1 receptors
subsequent to the proteolysis step [21,39]. The associa-
tion between IGFBP-1 and ECM/integrin results in a
decreased affinity for IGF-1, thus the IGFBP-1/IGF-1 com-
plex is modulated by ECM/integrin interaction
[16,20,21,39,40]. As for the extracellular regulators, the
role of IGFBP-1 deserves mention in this regard here, as
does further study of that role since little free IGF is detect-
able in the human serum in vivo. Most IGFs are bound to
larger proteins and only as little as 0.4% of total IGF-1 is
unbound and free in the serum [41].
As a coordinating factor, we chose the dephosphorylated
IGFBP-1 molecular complex to evaluate the influence of
IGFBP-1/IGF-1 upon embryo development, IGFBP-1
being clearly vital to the expression of IGF-1. In the results
of our experiments as depicted in Table 3, the synergistic
effect of the IGFBP-1/IGF1 complex embryo development
was significant. The rates of blastocyst formation and
hatching were both significantly elevated for the experi-
mental groups of IGFBP-1/IGF-1 as compared to the con-
trol group (blastocyst formation: 94.6% vs. 81.9%, p =
0.05; hatching: 68.8% vs. 48.6%, p < 0.05). The IGFBP-1
component of the IGFBP-1/IGF-1 complex used in our
studies was initially isolated from the human hepatoma
cell line Hep G2, and was found to exist primarily in its
phosphorylated form. To obtain the IGFBP-1/IGF-1 com-
plex, the IGFBP-1 moiety was dephosphorylated with
alkaline phosphatase and reacted with IGF-1 in a 1:1 ratio
(as per product information in Sigma No 12024; Sigma
catalogue). Therefore, it seems likely that the "used"
IGFBP-1 in our studies should be all dephosphorylated
and demonstrate a low affinity for IGF-1, such that the
resultant sequestration of IGF-1 due to the binding of IGF-
1 to IGFBP-1 should be minimal. Further, the IGF-1 mol-
ecule was able to be deactivated in the culture medium in
the presence of fetal calf serum (FCS), and the dephos-
phorylated IGFBP-1, in the form of an IGF-1/IGFBP-1
complex, was able to play a role in the preservation and
carriage of IGF-1. This effect appears to be more important
during the peri-implantation period and later embryo
development than at earlier stages of embryo develop-
ment [42].
IGFBP-1/IGF-1 complex decreases the level of apoptosis 
revealing an increased total cell number (TCN) for 
blastocysts
Several growth factors have been reported to be anti-apop-
totic; LIF, IL-6, TGF-α, EGF, IGF-1, IGF-II, and TGF-β etc.,
all appearing to be beneficial to post-thawed mouse blas-
tocysts as regards expansion in culture and subsequent
hatching [3]. LIF has been proposed to play a role in
maintaining the proliferative ability of ICM cells, yet it
failed to increase the total cell number of cultured blasto-
cysts, whilst TGF-α has been reported to demonstrate a
marginal potential to increase the cell number of blasto-
cysts [3]. There would appear to be several different path-
ways for these growth factors to benefit the embryos to
which they are exposed in culture, and also, there appear
to be several parameters that can be assessed in order to
reveal the relative positive effects of such growth factors,
these including cell number and accelerated develop-
ment, embryo grading, hatching ratio, and even zona pel-
lucida thickness variation [43]. The ultimate outcome for
the blastocyst is to become a viable embryo featuring an
abundance of pluripotential stem cells before and shortly
after implantation [44]. Therefore we choose cell number
per blastocyst and the passage of established stem-cell cul-
ture as the landmarks of the beneficial effect of growth fac-
tors upon embryo development for such potent mitogenic
agents as IGF-1 [14].
For the evaluation of the effects of the IGF-1/IGFBP-1
complex upon the total cell count of the blastocysts, we
randomly choose a selection of embryos cultured in
medium supplemented with IGF-1/IGFBP-1 complex and
a non-supplemented analogue for Hoechst 33342 stain-
ing. Fifteen embryos deriving from the IGFBP-1/IGF-1
group and 18 embryos from the control group were able
to be scored after having been successfully stained with
Hoechst 33342. This BisBenzimide fluorescent DNA stain
is plasma membrane permeable, and intercalates in the A-
T regions of the DNA molecule, it thus being useful for
staining DNA, chromosomes, and nuclei [45]. Thus,
Hoechst 33342 is able to stain the nuclei of both viable
and non-viable cells. Therefore, the total cell count of the
blastocysts which were enumerated for cell number was
determined by counting the total number of stained
nuclei at the end of culture using fluorescent microscopy.
Use of the Hoechst 33342 stain revealed that there was a
significant increase in the total cell number of blastocysts
in the IGFBP-1/IGF-1 group than was the case for the con-
trol group (87.6 ± 5.3 vs. 73.7 ± 7.1 respectively).
The total cell number of the blastocyst is dependent upon
the developmental environment and the particular stage
of the embryo at which it is assayed [6,44]. Over a similar
time course, blastocysts that developed in vivo revealed a
higher cell number than those cultured in vitro [6]. From
the results of Kamjoo's group (2002), the total cell
number of the murine blastocyst flushed from the uterus
on day four was, respectively, 87.4 ± 2 and 61.3 ± 4.4 cells
for mice of the C57BL6/CBA x C57BL6/CBA and MF1 x
MF1 strains of mice [6]. In the same study, the average
day-four TCN of blastocysts developed from in vivo ferti-
lized embryos cultured in vitro with kSOM was 55.0 ± 2.3
and 66.9 ± 1.6 cells for, respectively, C57BL6/CBA x
C57BL6/CBA and 57BL6/CBA x MF1 mouse strains [6]. In
our study, the embryos were flushed out from the oviducts
on day zero, after the confirmation of a vaginal plug hav-BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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ing developed. The in vivo fertilized embryos were then
cultured in kSOM/AA-supplemented medium either in
the presence or absence of IGFBP-1/IGF-1 until day 4.1
post-fertilization (day five morning). For our control
group (with no IGFBP-1/IGF-1 supplementation), the
mean TCN of the blastocysts was 73.7 ± 7.1 (Table 4),
such a figure being similar to that for the MF1 x MF1
embryo in kSOM-supplemented culture on the morning
of day five following pregnancy, as has been reported pre-
viously [6].
Certain apoptotic factors have been noted to be present in
the in vitro culture of mouse embryos, as evidenced by the
observation of the occurrence of developmental retarda-
tion and the level of apoptosis having both increased
amongst mouse embryos following in vitro culture [6,46].
The embryos cultured in vitro which is clearly a subopti-
mal condition as compared to the natural environment in
the uterus, have not only been deprived of a whole family
of necessary growth factors but have also faced exposure
to a variety of apoptotic factors in the in vitro environ-
ment, suggesting that a decrease in total cell number of
the blastocyst would likely be expected.
IGF-1 and embryonic stem-cell establishment
Early differentiation of the embryo leads the development
of two distinct lineages-the inner cell mass and the troph-
ectoderm [44,47]. For the mouse, a number of immortal
stem-cell lines can be obtained from both cell types [48].
The pluripotent internal cell component of the blastocyst,
the ICM, is segregated into a subcompartment, the epi-
blast, prior to blastocyst implantation [4,44]. It is evident
that ES cells originate from the epiblast, and isolation of
epiblast cells has been reported to enhance the efficiency
of ES cell derivation [49]. Prior to the induction of
diaphase (implantation delay), an increase in epiblast cell
numbers appears to enhance the efficiency of ES cell gen-
eration [50–52]. In our study, the significantly-increased
success in the establishment of a stem-cell line as
compared to control group was the indirect evidence sug-
gesting an increased level of viable cells in culture and a
decreased level of apoptosis for the blastocysts cultured in
medium supplemented with IGF-1 and IGFBP-1/IGF-1.
Conclusion
The supplementation of culture medium with IGF-1 100
ng/ml significantly increased blastocyst formation from in
vivo fertilized/in vitro cultured embryos, the increase being
8.3%. Although such a result was statistically-significant,
the increase, however, appeared mediocre. IGFBP-1 con-
trols IGF's action at the cellular level by regulating the
access of IGFs to appropriate receptors as well as at a
microenvironment level where IGFBP-1 acts as a carrier
and reservoir for IGF-1 [16,20,21,40]. Dephosphorylated
IGFBP-1 with a low affinity for IGF-1 encourages the
IGFBP-1/IGF-1 complex to elicit a similar beneficial effect
to IGF-1 upon the cultured embryo, the effect being, prin-
cipally, to enhance blastocyst formation. A synergistic
effect of dephosphorylated IGFBP-1/IGF-1 appears possi-
ble, since from our study, the hatching rate also appeared
to have increased for embryos cultured in medium sup-
plemented with this complex when compared to those
cultures supplemented with IGF-1 only.
Arrested embryos may be free from the presence of
Annexin V staining positivity in the cell membrane and
also free from PI staining positivity in the nucleus, such an
outcome suggesting that Annexin V (positive) staining of
the arrested embryos reveals that apoptosis is a late event
in the development of the compromised embryos. Those
arrested embryos, which did not normally demonstrate
any mitogenic activity but still maintained normal
biological activity therefore must have maintained a nor-
mal Annexin V stain-free plasma membrane. Necrotic
changes in the blastomere of the embryo, as revealed by PI
staining, appear to be a much later event for the compro-
mised embryos. PI-stained cells were only found in the
arrested embryos for either the IGF-1 group or the control
group. Annexin V revealed apoptosis of embryo cells was
able to be detected, although seldom, in the well-devel-
oped blastocysts of the control group. IGF-1 decreased the
level of apoptosis for cells in blastocysts cultured in vitro.
Therefore, IGF-1 has truly elicited a significant anti-apop-
totic and an anti-necrotic effect upon the preimplantation
development of experimental in vivo fertilized/in vitro cul-
tured embryos.
IGFBP-1/IGF-1 increased the total cell number of in vitro
cultured blastocysts, we noting an 18.9% increase in the
total cell number of the blastocysts for the IGFBP-1/IGF-
1-supplemented group as compared to the control group.
The anti-apoptotic effect provided by IGF-1 decreased the
triggering of cell death in culture, and enhanced the
chances of the proliferation of viable cells. Therefore, in
this study, IGF-1 contributed to a net increase in the total
cell number of those blastocysts cultured in vitro.
Blastocysts cultured in IGF-1- and IGFBP-1/IGF-1-supple-
mented medium revealed a significantly-increased
number of viable cells for subsequent embryos. The
greater the number of viable cells in the hatching blasto-
cysts the greater will be the subsequent ICM and the
number of epiblast cells [53,54]. The greater the total ICM
and the greater the number of epiblast cells that were
placed in culture, the greater the number of subsequent
colonies that could be derived and the greater the chances
for subsequent successful stem-cell line establishment.
The facilitated enhanced efficiency of ICM-derived colony
formation and stem-cell line establishment in this study
implies that IGF-1 or IGFBP-1/IGF-1 supplementation ofBMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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culture medium increases the viable cell numbers for the
involved cultured blastocyst.
Materials and methods
Collection and in vitro culture of in vivo zygotes
All embryos used in this study were collected from F1
female mice (C57BL/6 J x C3H, six to eight weeks old)
mated with C3H males. Mice were maintained under a
daily light regime of 14 hours L: 10 hours D (Light: Dark).
Female mice were superovulated by an injection of preg-
nant mare serum gonadotropin (5IU; PMSG, Sigma, St
Louis, MO, USA) at 5 p.m., followed by an injection of
human chorionic gonadotrophin (5IU; hCG, Sigma, St
Louis, MO, USA) 48 hours later. Females were placed in
cages with males subsequent to the administration of
hCG to the former. On the following morning, the
females were examined for the presence of a vaginal plug.
Females exhibiting a vaginal plug were sacrificed 16 hours
post-hCG injection by means of cervical dislocation and
their oviducts were excised. The in vivo fertilized zygotes
were then flushed out from the oviducts of these mice
[47]. The embryos so collected were randomly allocated
to control and treatment groups with different in vitro cul-
ture conditions. In each repeat experiment, three to four
pairs of successfully mated mice were used and the results
of each experiment were pooled from several repeats.
Preparation of culture media for each experiment
The culture medium used in our study was kSOM/AA
medium [23,24,35,55] and all other chemicals used in
this study were purchased from Sigma Chemicals unless
otherwise specified.
Experiment 1
The in vivo fertilized zygotes were randomly allocated into
control and treatment groups. There were totally 83
zygotes in the control group and 106 zygotes in the exper-
iment group in the five repeats of experiments. For the
control group, the embryos were cultured in kSOM/AA
medium. Further supplementation of the culture medium
used to culture the embryos in the treatment group was
made with insulin-like growth factor-1 (IGF-1; 100 ng/
ml). The developmental stages of the various cultured
embryos were evaluated daily until day 4.3 post-fertiliza-
tion (24 hr × 5 – 5 hr post-hCG injection - 12(11–13.5)hr
ovulation time after hCG injection [44]: day five noon).
Apoptosis was evaluated using Annexin V and PI staining
under fluorescent microscopy.
Experiment 2
Seventy-two in vivo fertilized zygotes in the control group
were cultured in kSOM/AA medium as indicated above. In
the culture medium for the 93 in vivo fertilized zygotes in
the treatment group, insulin-like growth factor binding
protein-1/IGF-1 complex (IGFBP-1/IGF-1) was supple-
mented (100 ng/ml). The evaluation of the developmen-
tal competence of cultured embryos was performed as
described above for experiment one.
Experiment 3
Forty-five in vivo fertilized zygotes in the control group
were cultured in kSOM/AA medium. For the culture
medium for 38 in vivo fertilized zygotes in the treatment
group, further supplementation of IGFBP-1/IGF-1 was
made (100 ng/ml). Blastocyst-stage embryos obtained
both from the control and treatment groups on day 4.1,
measured from time of fertilization, i.e. 12 hr(11–13.5 hr)
after hCG induced ovulation (24 hr × 4 + 16 hr post-hCG
injection - 12(11–13.5)hr ovulation time after hCG injec-
tion [44]: day five morning) were fixed for cell-number
evaluation.
Experiment 4
The medium used for the in vitro culture of embryos cor-
responding to the control group was kSOM/AA. The
medium for one experimental group was kSOM/AA sup-
plemented with IGF-1 (100 ng/ml); the medium for the
other experimental group was kSOM/AA supplemented
with IGFBP-1/IGF-1 complex (100 ng/ml). The
experiment was pooled from 3 repeats and there were
totally 11, 12, and 13 hatched blastocysts in control, IGF-
1, and IGFBP-1/IGF-1 groups respectively. The methods
used for the establishment of embryonic stem cells in this
study was that described in 1983 by Kaufman at al. [51]
using STO cells here as the necessary feeder cells.
Culture of embryos
The in vivo fertilized zygotes were cultured in three types
of culture medium, kSOM/AA, kSOM/AA with 100 ng/ml
IGF-1, and kSOM/AA with 100 ng/ml IGFBP-1/IGF-1
complex, respectively, at 37°C in an atmosphere of 5%
CO2-in-air. For experiments 1 and 2, the final stages of
development of the cultured embryos were determined
on day 4.3 post fertilization under an inverted micro-
scope. For experiment 3, the cultured blastocyst-stage
embryos obtained on day 4.1 post-fertilization were cul-
tured in Hoechst H33342 (5 µg/ml; Sigma, St Louis, MO,
USA) staining medium in DPBS at 37°C with 5% CO2 for
a period of three to five minutes. The cell numbers of
these cultured blastocyst-stage embryos were then enu-
merated under a fluorescence microscope following fixa-
tion. For experiment 4, the hatched blastocysts obtained
from in vitro culture on day 4.3 post-fertilization were
placed into feeder cell-containing wells with ES
medium.[51] for establishment of embryonic stem-cell
lines.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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Fluorescent staining with Annexin V-FITC, propidium iodide (PI) and 
Hoechst 33342 stain
The embryos subjected to Annexin V and PI staining were
dual stained in phosphate-buffed saline (PBS) containing
fluorescein isothiocyanate (FITC) conjugate of Annexin V
(1 µg/mL) and propidium iodide (500 ng/mL) at 37°C
for 45 minutes. The embryos were then examined under
epifluorescent fluorescence microscopy using a Leitz
4867709 Cube microscope (BP450-490/FT510/LP520)
for Annexin V - FITC and a Chroma 31005 cube micro-
scope (propidium iodide cube) for PI. As for TCN count-
ing, the individual blastocysts were incubated in a droplet
of Hoechst 33342 for three to five minutes at 37°C and
then fixed for fluorescence examination under epifluores-
cent fluorescence microscopy using a Leitz 4867709 Cube
microscope [56].
Preparation of feeder dishes
The procedure for the preparation of feeder dishes was
modified from a technique suggested by Hogan et al. in
1994 [44,47]. Briefly, confluent STO cells (National
Health Research Institutes, Taiwan) in tissue culture
dishes were treated with freshly-prepared DMEM plus
10% fetal calf serum (FCS) and mitomycin C (10 ug/ml),
following which, the dishes were returned to a humidified
incubator at 37°C with a 5% CO2-in-air atmosphere for a
period of two-to-three hours. Following this, the dishes
were washed extensively with several changes of Dul-
becco's Phosphate Buffered Saline (DPBS) and the cells
subsequently collected by trypsinization. Following this,
the cells were sedimented by low-speed centrifugation
(1,000 rpm for a period of five minutes), and then the pel-
let was resuspended with fresh DMEM plus 10% FCS, and
the cells counted, and then diluted DMEM plus 10% FCS
to yield a final cell density of 3 × 105/ml. Next, the cells so
prepared were placed into tissue culture dishes (Nunclon
153066) which had been pretreated with collagen. The
collagen-pretreating procedure for the dish was per-
formed by flooding the dish with a 0.1% solution of col-
lagen for a period of two hours, following which, the
collagen was removed.
Culture of embryonic stem (ES) cells (Figure 4)
The hatched blastocysts recovered from the 3 different in
vitro culture media, as shown in experiment 4, were
implanted into feeder wells, as day zero of de novo isola-
tion of embryonic stem cells. By day five to six, the ICM
transformed into a distinct cellular mass (Figure 4B)
within the trophoblast outgrowth, which were extracted
and washed initially with Ca++/Mg++- free PBS, then incu-
bated in PBS with 0.25% trypsin/0.2%EDTA as an addi-
tive. resulting in a clump of cells. A pasteur pipette was
used to gently separate the clump of cells into smaller
aggregates (Figure 4C), which were implanted into 4 fresh
feeder wells allowing them to grow until the 12th or the
13th day. (The ES-like cell clump from each blastocyst was
implanted into 4 labeled wells. The establishment of ES
cell line was traced back to these original labeled wells).
Growths resembling stem cells were drawn out from the
culture media and subjected to disaggregating process
during day 5–6, only this time the cells were separated
into single cells. These were collected and reseeded into
new culture feeder wells and allowed to grow for another
4–5 days before stem cell-like growths were again drawn
out and segregated for another repeat culture (day 17–
18). At this subculture, the successful growth of stem cells
was labeled as 1st generation of embryonic stem cells. Suc-
cessful and unsuccessful culture of stem cells arising from
a common blastocyst were followed for 3 more genera-
tions at an interval of four-to-five days in order to estab-
lish permanent ES cell lines (Figure 4D). Together with
the unsuccessful ones, the permanent ES cell lines were
traced to the initial common blastocyst and labeled wells
of cellular aggregates separated from ICM-derived cellular
clump and accounted accordingly. (modified from Hogan
et al.1994) [44,47].
List of abbreviations used
Bax: Bcl-2 associated X protein
Bcl-2: a human proto-oncogene discovered as the translo-
cated locus in a B-cell
DMEM: Dulbecco's Modified Eagle's Medium.
Table 5: Subsequent stem-cell establishment from the hatched blastocysts derived from IGF-1- or IGFBP-1/IGF-1-supplemented 
embryo culture.
Culture Medium No. of hatched blastocysts tested No. of blastocysts up to three passages (%) to 
establish ES cell lines
No of wells * (%) of established ES cell lines
kSOM/AA with IGF-1 12 6 (50) 22(45.8) **
kSOM/AA with IGFBP-1/IGF-1 13 8(61.5) 31(59.6) **
kSOM/AA 11 4(36.3) 12(27.3)
The results were pooled from 3 repeats of experiments. * The cellular clump from ICM of each blastocyst was dissociated and implanted into four 
separate culture wells, which were labeled and traced back after the establishment of ES cell line. ** P < 0.05BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/14
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DNA: deoxyribonucleic acid
DPBS: Dulbecco's Phosphate Buffered Saline.
ECM: Extracellular Matrix
EGF: epidermal growth factor
FCS: newborn calf serum, fetal calf serum
β-FGF: β-fibroblast growth factor
ES cell: embryonic stem cell
FITC: fluorescein isothiocynate
GH: growth hormone
H33342: Hoechst BisBenzimide 33342
hCG: human chorionic gonadotrophin
ICE: interleukin-1b converting enzyme
ICM: inner cell mass
IGF-1: insulin like growth factor-1
IGF-2: insulin like growth factor-2
IGFBP-1: insulin like growth factor-1 binding protein
IGF-1R: IGF-1 receptor
IL-6: interleukin-6
IRS-1: insulin receptor substrate-1
IVF: in vitro fertilization
kSOM/AA: kSOM with amino acids
LIF: leukemia inhibitory factor
PAF: platelet activating factor
PBS: phosphate-buffed saline
PI: Propidium Iodide
PI3-kinase: phosphatidylinositol 3-kinase
STO: A permanent cell line derived from mouse fetal
fibroblasts.
TCN: total cell number
TGF-α: transforming growth factor-α
TGF-β: transforming growth factor-β
TUNEL: terminal deoxynucleotidyltransferase-mediated
dUTP nick end labeling
UV radiation: ultraviolet light radiation
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